“ACHILLES” Heel No More? Afatinib at 40 Mg Once Daily is Superior to Platinum-Based Chemotherapy in EGFR Uncommon (G719X, S768I, and L861Q) Mutations (ACHILLES/TORG1834)

Faustine X Luo,1,2 Sai-Hong Ignatius Ou1,2 1Chao Family Comprehensive Cancer Center, Orange, CA, 92868, USA; 2University of California Irvine School of Medicine, Orange, CA, 92868, USACorrespondence: Sai-Hong Ignatius Ou, University of California Irvine School of Medicine, Chao Family Comprehensive...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Luo FX, Ou SI
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Dove Medical Press 2024-05-01
coleção:	Lung Cancer: Targets and Therapy
Assuntos:	afatinib uncommon egfr mutations g719x s768i l861q achilles relative dose intensity
Acesso em linha:	https://www.dovepress.com/achilles-heel-no-more-afatinib-at-40-mg-once-daily-is-superior-to-plat-peer-reviewed-fulltext-article-LCTT
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!